Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
69 participants
INTERVENTIONAL
2019-09-01
2022-09-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
. All the patients will receive general anesthesia.
The patients will be randomly allocated into one of the following two groups;- - Control group (30 patients): The patients in this group will receive sham rhomboid intercostal and subserratus plane.
\- Rhomboid intercostal and subserratus plane block group (30 patients): The patients in this group will be receive real ultrasound-guided rhomboid intercostal and subserratus plane.
The primary outcome measure will be the total dose of morphine consumed in the first 24 h after surgery and the secondary outcome will be the postoperative pain score.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rhomboid Intercostal Block Versus Serratus Anterior Plane Block
NCT05661279
Serratus Anterior Plane Block and Costotransverse Block for Analgesia Following Modified Radical Mastectomy Surgeries
NCT06260397
Rhomboid Intercostal Block vs Erector Spina Plan Block for Peri-operative Analgesia in Mastectomy
NCT04259502
Rhomboid Intercostal Block With Sub-Serratus Plane Block Versus Erector Spinae Block
NCT07041762
Serratus Posterior Superior Intercostal Plane Block, Versus Erector Spinae Facial Plane Blocks
NCT06989372
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Any unexpected risks that will appear during the research will be announced to the participants and to the ethical committee at time and adequate measures will be taken to resolve and avoid these risks.
Expected risks to the patients: patients enrolled in this study will minimal risk of local hematoma that which will be managed by adequate compression and minimal risk of infection that will be guarded against by adequate sterilization and prophylactic antibiotic.
There will be adequate supervision to maintain the privacy of patients and confidentiality of data.
There will be no conflict of interest, nor conflict with religion, law, or society standards.
The research will be beneficial to the society and has no risk of environmental pollution.
Upon arrival of the patient to the operating room, intravascular access will be established, fluid preload will be started, and basic monitor will be attached. After positioning and adequate sterilization of the back. The patients will be randomly allocated into two equal groups by the aid of computer-generated software of randomization; - • Control group (30 patients): The patients in this group will receive sham rhomboid intercostal and subserratus plane.
• Rhomboid intercostal and subserratus plane block group (30 patients): The patients in this group will be receive real ultrasound-guided rhomboid intercostal and subserratus plane.
Anesthesia will be induced by fentanyl 1 ug/kg, propofol 1.5 mg/kg, and cis-atracurium 0.15 mg/kg to facilitate tracheal intubation. After endotracheal intubation, the patients will be connected to a mechanical ventilator with its parameters adjusted to maintain etCo2 32-36 mmhg. Anesthesia will be maintained by isoflurane 1% MAC in mixture of oxygen:air 1:1 with the use of low flow (1 ml/min).
All the patients will be connected to a bispectral index monitor with maintaining its value ranging 40-60. Increase in the BIS value over 60 will be managed by additional dose of fentanyl 1ug/kg till decrease the BIS below 60. If the BIS is still over 60, increasing the isoflurane 0.2 % MAC till it decreased below 60.
At the end of the surgery, switching off the inhalational anesthetics, reversal of muscle relaxation, and awake tracheal extubation will be done with transporting the patients to the PACU for postoperative follow up and monitoring.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Outcome assessors will be blinded as they will be anesthesia resident and nurse not participating in the study.
The investigators will be blinded
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
The patients in this group will receive sham rhomboid intercostal and subserratus plane.
Control group
The patients in this group will receive sham rhomboid intercostal and subserratus plane.
Rhomboid intercostal and subserratus plane block group
The patients in this group will be receive real ultrasound-guided rhomboid intercostal and subserratus plane.
Rhomboid intercostal and subserratus plane block group
The patients in this group will be receive real ultrasound-guided rhomboid intercostal and subserratus plane.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control group
The patients in this group will receive sham rhomboid intercostal and subserratus plane.
Rhomboid intercostal and subserratus plane block group
The patients in this group will be receive real ultrasound-guided rhomboid intercostal and subserratus plane.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 40-75 years
* ASA class I-II
* Presented for elective radical mastectomy.
Exclusion Criteria
* Patients with known or suspected allergy to the used medication.
* Patients with preoperative chronic pain
* Patients received preoperative opioids or gabapentoids.
* Patients with major cardiac, renal, respiratory, or hepatic disease.
* Patients with potential risk of coagulopathy
* Uncooperative patients.
* Obese patients with BMI \>36
40 Years
75 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr. Mohamed shebl Abdelghany
UNKNOWN
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sameh Abdelkhalik Ahmed Ismaiel
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sameh Ismaiel, M.D
Role: PRINCIPAL_INVESTIGATOR
Lecturer of Anesthesia and Intensive Care, Tanta University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta University hospitals
Tanta, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
33206/07/19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.